The Goldman Sachs Group
Qiming-backed Biopharma Firm Gan & Lan Seeks To Raise $359m In Shanghai IPO
Business - Published date: .
Gan & Lee Pharmaceuticals has kicked off its IPO subscription exercise as it seeks to bag a total of 2.5 billion yu... Read more